ADC Therapeutics S.A. ( ADCT) - Key Metrics
ADCT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.15 | -$0.04 | -$0.21 | -$0.21 |
| 2025Q3 | $0.12 | -$0.30 | -$0.22 | -$0.22 |
| 2025Q2 | $0.17 | -$0.50 | -$0.21 | -$0.21 |
| 2025Q1 | $0.21 | -$0.36 | -$0.53 | -$0.53 |
ADCT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -20.70 |
| 2025Q3 | ? | -3.33 |
| 2025Q2 | ? | -1.35 |
| 2025Q1 | ? | -0.98 |
ADCT
Price: $1.32
52 week price:
Earnings Per Share: -0.97 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Country: Switzerland
Volume: 1.0 million
Market Capitalization: 445.2 million